HIPK2 and colorectal cancer: As a proof of principle, inhibition of NRF2 has been shown to selectively induce cell death in NRF2-addicted colorectal cancer cells by promoting ferroptosis and pyroptosis [112,113] and to increase chemotherapy response only when HIPK2 is expressed [71].